Q: Does Knight Therapeutics have any connections with Astra Zeneca?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hi,
DOC: I am looking at cloud md as a speculative growth buy. It is in the same space as WELL and recently closed an acquisition. Financials expected end of month. (comments on anticipated results appreciated) I know it is early days but I think it has potential. Any insights on the potential for this sector generally and the company in particular are much appreciated.. As always thanks for the services you provide.
DOC: I am looking at cloud md as a speculative growth buy. It is in the same space as WELL and recently closed an acquisition. Financials expected end of month. (comments on anticipated results appreciated) I know it is early days but I think it has potential. Any insights on the potential for this sector generally and the company in particular are much appreciated.. As always thanks for the services you provide.
Q: Good day guys:
Opinion of this name please .. is it a buy?
Thx
Mark
Opinion of this name please .. is it a buy?
Thx
Mark
Q: WELL is on an unbelievable run. What do you see as the end game for this company in 2-3 years? A tuck in acquisition for a larger company or a successful standalone?
Q: I have held GUD for years, with very little growth. I am thinking of selling and buying WELL. Which of these stocks do you believe will have better growth and which do you consider less of a risk. Thank you
Q: The price of BNTX has been languishing to $68 since the stock offer at $93 per share in the July. Please help me to understand the reasons of the decline if any. Thank you very much. Bill.
Q: Hi folks, can please get update on your thoughts on Neptune Wellness....into cannabis but also couple of Covid 19 products. Just posted Q2/20 results which showed good growth in revenue & gross profit QoQ, but loss of $11M. Would U rate the stock a buy,hold,sell...or avoid. Thanks as always, jb
Q: In the WELL conference call the CEO made reference to this US company in the same space. Do you know if ONEM is a disciplined capital allocator. Or do they just acquire assets, issue a ton of shares/debt and really not the move the per share earnings needle? Does ONEM look like a good investment?
Q: The only reason they beat with .13 is because they had a "net gain of financial instruments measured at fair value" of $16,499. Last Q, they had a loss.
This number is the reason why it was .13 and not negative.
How valid is this and should this not to be taken out and adjusted to a lower EPS?
Thanks
This number is the reason why it was .13 and not negative.
How valid is this and should this not to be taken out and adjusted to a lower EPS?
Thanks
Q: You said we expect $50.76 mln and EPS of -$0.03 from GUD.
They made a big acquisition which has long closed and we are not
seeing the benefits on the top and bottom lines.
What use is it to hold GUD?
They made a big acquisition which has long closed and we are not
seeing the benefits on the top and bottom lines.
What use is it to hold GUD?
Q: please comment on recent Q results of SIS.Is it time to add my 3.5% pos.Txs for u usual great services& views
Q: I'm trying to get a handle on VMD's valuation; the equity has fallen sharply in the face of what appear to be outstanding results and expressions of continuing responsiveness by management with respect to their prospects. Yet the market seems to be pricing the company as a one trick (Covid 19) exploitive pony. Or perhaps not? And is the overhang from prior days and the accompanying critique still valid? Thank you for your consideration.
Q: I would like your opinion on Centene and Merck? Is valuation good? can you suggest any other US healthcare companies? Do you anticipate growth in this area?
thanks
thanks
Q: What are the Expectations of SIS Savaria for 2nd quarter. Been on a good run last month. What are the expectations for the rest of the year. Barry F
Q: Hi team,
Can I get your thought on the quarter out of WELL?
Thanks!
Can I get your thought on the quarter out of WELL?
Thanks!
Q: Hello guys:
I know this name had a great quarter and lots of momentum at this point, would you guys own this name?
Thx for your great work and being prompt at asking our questions for us retail investors .
Mark
I know this name had a great quarter and lots of momentum at this point, would you guys own this name?
Thx for your great work and being prompt at asking our questions for us retail investors .
Mark
-
Teladoc Health Inc. (TDOC $7.68)
-
WELL Health Technologies Corp. (WELL $4.92)
-
Livongo Health Inc. (LVGO $132.68)
-
1Life Healthcare Inc. (ONEM)
Q: looking for a US/Cdn company in the tele-medicine space. Not ones with a pricey valuation like TDOC. Do you have any recommendations.
Q: Please comment the Q2 reports for CDAY if you haven't already answered this question before. Thanks
Q: I have been following CVS for several years now, and currently hold a half position. During the past Q they were able to top analyst estimates for both revenue and EPS. They are also paying down their debt due to the purchase of Aetna. What do you think of their future prospects as a dividend income investment with some stock price appreciation?
Q: Hello Peter, many individual investors (certainly I) have terrible timing on their transactions. For example, if one has been following Becton Dickinson, looking to buy, one might be happy to see this morning's 8% drop and immediately place their order. How do you handle this type of situation? Wait and see where the dust settles? Jump on the 'new lower price'? Or wait some days or weeks to see a base and an upturn? Would you be comfortable buying BDX today, for the long term?